Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Prevalence of human herpesvirus U94/REP antibodies and DNA in Tunisian multiple sclerosis patients.
[Differential diagnosis of late-stage neuroborreliosis with affection of the central nervous system.]
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany.
Sarcoidosis Triggered by Interferon-Beta Treatment of Multiple Sclerosis: A Case Report and Focused Literature Review.
Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ
[HTLV-1-associated myelopathy/tropical spastic paraparesis : A differential diagnosis in multiple sclerosis.]
Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis.
Structural mechanism for statin inhibition of HMG-CoA reductase.
Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis.
Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension.
Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.
Substance Name: Riluzole
Comparison of DNA-Hydrolyzing Antibodies from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiple sclerosis.
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.
A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers.
Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients.
Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases.
Patients' experiences of adapting to multiple sclerosis: a qualitative study.
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
First patient enrolled in third Phase III study of oral laquinimod for relapsing-remitting multiple sclerosis
Symptoms, Prevalence and Impact of Multiple Sclerosis in Younger Patients: A Multinational Survey.
Acute reversible periependymal ventricular enhancement in neuromyelitis optica.
Dynamics of saccade parameters in multiple sclerosis patients with fatigue.
Enhanced myelination in autoimmunity and in normal development induced by glatiramer acetate.

Pages